Secondary amyloidosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 10: | Line 10: | ||
|+ | |+ | ||
|- | |- | ||
| | | colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" |'''Differential diagnosis of secondary amyloidosis''' | ||
|- | |- | ||
| rowspan="4" align="center" style="background:#f0f0f0;" |Nephrotic syndrome causes | | rowspan="4" align="center" style="background:#f0f0f0;" |'''Nephrotic syndrome causes''' | ||
| | | | ||
* Minimal change disease | *'''Minimal change disease''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Membranous nephropathy | *'''Membranous nephropathy''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Focal segmental glomerulosclerosis | *'''Focal segmental glomerulosclerosis''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Diabetic nephropathy | *'''Diabetic nephropathy''' | ||
* | * | ||
|- | |- | ||
| rowspan="5" |Hepatosplenomegaly causes | | rowspan="5" |'''Hepatosplenomegaly causes''' | ||
| | | | ||
* Metabolic disorders | *'''Metabolic disorders''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Chronic liver disease and portal hypertension | *'''Chronic liver disease and portal hypertension''' | ||
|- | |- | ||
| | | | ||
* Infectoins | *'''Infectoins''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Hematologic disorders | *'''Hematologic disorders''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Rare disorders | *'''Rare disorders''' | ||
* | * | ||
|- | |- | ||
| rowspan="2" |Peripheral neuropathy causes | | rowspan="2" |'''Peripheral neuropathy causes''' | ||
| | | | ||
* Neurologic disorders | *'''Neurologic disorders''' | ||
* | * | ||
| Line 67: | Line 66: | ||
|- | |- | ||
| | | | ||
* Inflammatory disorders | *'''Inflammatory disorders''' | ||
* | * | ||
| Line 75: | Line 74: | ||
| align="center" style="background:#f0f0f0;" | | | align="center" style="background:#f0f0f0;" | | ||
| | | | ||
* Toxins | *'''Toxins''' | ||
* | * | ||
| Line 81: | Line 80: | ||
| rowspan="3" | | | rowspan="3" | | ||
| | | | ||
* Vitamin deficiencies | *'''Vitamin deficiencies''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Metabolic disorders | *'''Metabolic disorders''' | ||
* | * | ||
|- | |- | ||
| | | | ||
* Genetic disorders | *'''Genetic disorders''' | ||
* | * | ||
Revision as of 19:59, 4 November 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.
Differentiating Amyloidosis from other Diseases
Secondary amyloidosis needs to be differentiated from other conditions causing nephrotic syndrome, hepatosplenomegaly, and peripheral neuropathy.
| Differential diagnosis of secondary amyloidosis | |
| Nephrotic syndrome causes |
|
| |
| |
| |
| Hepatosplenomegaly causes |
|
| |
| |
| |
| |
| Peripheral neuropathy causes |
|
| |
| |
| |
| |
| |